Continental Chemicals Ltd

The next results date for Cont. Chemicals is 13 November 2025.

Cont. Chemicals has experienced a declining trend in net sales and profitability, with net sales dropping from 0.44 Cr in Mar'23 to 0.22 Cr in Mar'25, and operating profit worsening to -0.76 Cr in Mar'25. Despite reporting a profit before tax of 0.48 Cr in Mar'25, overall financial performance has shown significant volatility.

Cont. Chemicals will declare its results on 08 August 2025.

As of 24th July, Continental Chemicals Ltd has a market capitalization of 17.00 Cr, with recent net sales of 0.35 Cr and a net loss of 0.30 Cr over the last three quarters. Shareholder's funds are valued at 4.59 Cr, and total assets amount to 5.57 Cr.

The top shareholder of Cont. Chemicals is Aditya Vikram Chibba, who holds 55.66% of the shares. Promoters own the majority, with individual investors holding 37.62%, and there are no pledged holdings or investments from mutual funds or foreign institutional investors.

As of June 6, 2025, the technical trend for Cont. Chemicals is mildly bearish, supported by bearish MACD indicators, moving averages, and Bollinger Bands across weekly and monthly time frames.

As of April 25, 2023, Cont. Chemicals is rated as risky and overvalued with a PE ratio of 15.52, an EV to EBIT of -12.57, and a year-to-date return of -29.22%, contrasting sharply with the Sensex's 5.63% gain.

Cont. Chemicals has experienced a declining trend in net sales and operating income from March 2022 to March 2025, resulting in operating losses, despite an increase in other income. The company's total assets and liabilities have risen, but cash flow remains stagnant, indicating challenges in revenue generation and cost management.

Cont. Chemicals has experienced a declining trend in net sales and operating income from March 2022 to March 2025, resulting in operating losses, despite an increase in other income. The company's total assets and liabilities have risen, but cash flow remains stagnant, indicating challenges in revenue generation and cost management.

Continental Chemicals Ltd is a micro-cap company in the software products industry, primarily manufacturing soaps and detergents. As of March 2025, it reported net sales and profit of 0 Cr, with a market cap of Rs 15 Cr.

As of March 2023, the management team of Cont. Chemicals includes Pradeep Chopra (Chairman), Naresh K Chibba (Managing Director), Sunaina Chibba, Akshat Bhaskar, and Aditya Vikram Chibba. Only Naresh K Chibba receives remuneration, totaling Rs. 11.76 lacs.

Peers of Cont. Chemicals include Oracle Fin.Serv., C.E. Info System, Tanla Platforms, Moschip Tech., Nucleus Soft., Indo-City Info., Hind.Bio Science, and First Fintec. Hind.Bio Science has the highest 1-year return at 19.58%, while Tanla Platforms has the lowest at -32.80%, with Cont. Chemicals at -7.18%.